SCHEMBL5155452

SCHEMBL5155452

CCOc1ccc(-c2cc(OC)c(OC)c(OC)c2)cc1C(=O)N[C@@H](CO)Cc1c[nH]c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 1/20 0.49
THRB P10828 1/20 0.49
KDM4E B2RXH2 1/20 0.49
PTGS2 P35354 1/20 0.47
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
HDAC3 O15379 5/20 0.45
HDAC1 Q13547 5/20 0.45
HDAC2 Q92769 5/20 0.45
HDAC6 Q9UBN7 4/20 0.45
HDAC4 P56524 3/20 0.45
HDAC7 Q8WUI4 3/20 0.45
HDAC10 Q969S8 3/20 0.45
HDAC11 Q96DB2 3/20 0.45
HDAC8 Q9BY41 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603018 0.94 KMT2A (0.55) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14557757 0.94 KMT2A (0.52) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL5149313 0.94 KMT2A (0.48) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14557605 0.91 MAPT (0.48) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14610510 0.90 KMT2A (0.46) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14557604 0.90 KMT2A (0.46) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL5151440 0.90 HDAC3 (0.47) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14557765 0.90 KMT2A (0.49) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14610493 0.90 CDK4 (0.52) KMT2AMEN1MAPTHPGDSMN1; SMN2
SCHEMBL14557636 0.90 CDK4 (0.52) KMT2AMEN1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R KMT2A 916/4885MEN1 410/4885MAPT 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.